84 related articles for article (PubMed ID: 25669749)
21. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
Jóźwiak S; Nabbout R; Curatolo P;
Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Whittemore VH; Thiele EA; Ford JP; Shah G; Cauwel H; Lebwohl D; Sahmoud T; Jozwiak S
Lancet; 2013 Jan; 381(9861):125-32. PubMed ID: 23158522
[TBL] [Abstract][Full Text] [Related]
23. Tuberous sclerosis complex: genotype/phenotype correlation of retinal findings.
Aronow ME; Nakagawa JA; Gupta A; Traboulsi EI; Singh AD
Ophthalmology; 2012 Sep; 119(9):1917-23. PubMed ID: 22608477
[TBL] [Abstract][Full Text] [Related]
24. Thyroid transcription factor-1 and epithelial membrane antigen expression in four cases of subependymal giant cell astrocytoma.
Chatzopoulos K; Koletsa T; Iliadis A; Karkavelas G; Kostopoulos I
Histopathology; 2015 Jun; 66(7):1035-6. PubMed ID: 25195621
[No Abstract] [Full Text] [Related]
25. The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex.
Amin S; Carter M; Edwards RJ; Pople I; Aquilina K; Merrifield J; Osborne JP; O'Callaghan FJ
Eur J Paediatr Neurol; 2013 Jan; 17(1):36-44. PubMed ID: 23183057
[TBL] [Abstract][Full Text] [Related]
26. Neonatal subependymal giant cell astrocytoma: new case and review of literature.
Raju GP; Urion DK; Sahin M
Pediatr Neurol; 2007 Feb; 36(2):128-31. PubMed ID: 17275668
[TBL] [Abstract][Full Text] [Related]
27. Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex.
Birca A; Mercier C; Major P
J Neurosurg Pediatr; 2010 Oct; 6(4):381-4. PubMed ID: 20887114
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of the WNT pathway in tuberous sclerosis-associated subependymal giant cell astrocytomas.
Jozwiak J; Kotulska K; Grajkowska W; Jozwiak S; Zalewski W; Oldak M; Lojek M; Rainko K; Maksym R; Lazarczyk M; Skopinski P; Wlodarski P
Brain Dev; 2007 Jun; 29(5):273-80. PubMed ID: 17071037
[TBL] [Abstract][Full Text] [Related]
29. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.
Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104
[TBL] [Abstract][Full Text] [Related]
30. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
[TBL] [Abstract][Full Text] [Related]
31. [Subependymal giant cell astrocytoma].
Altermatt HJ; Shepherd CW; Scheithauer BW; Gomez MR
Zentralbl Pathol; 1991; 137(2):105-16. PubMed ID: 1911724
[TBL] [Abstract][Full Text] [Related]
32. Basal ganglia location of subependymal giant cell astrocytomas in two infants.
Işik U; Dinçer A; Sav A; Ozek MM
Pediatr Neurol; 2010 Feb; 42(2):157-9. PubMed ID: 20117758
[TBL] [Abstract][Full Text] [Related]
33. Subependymal giant cell astrocytoma.
Ahmad Z; Rauf F; Azad NS; Ahsan A
J Pak Med Assoc; 2006 Oct; 56(10):463-5. PubMed ID: 17144395
[TBL] [Abstract][Full Text] [Related]
34. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA
J Pediatr; 2014 May; 164(5):1195-200. PubMed ID: 24518170
[TBL] [Abstract][Full Text] [Related]
35. Cytomorphology of subependymal giant cell astrocytoma.
Altermatt HJ; Scheithauer BW
Acta Cytol; 1992; 36(2):171-5. PubMed ID: 1543002
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of glutamate receptor subunit 2(3) in subependymal giant-cell tumor.
Arai Y; Takashima S; Becker LE
Pediatr Neurol; 2000 Jul; 23(1):37-41. PubMed ID: 10963968
[TBL] [Abstract][Full Text] [Related]
37. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
[TBL] [Abstract][Full Text] [Related]
38. Cytologic characteristics of subependymal giant cell astrocytoma in squash smears: morphometric comparisons with gemistocytic astrocytoma and giant cell glioblastoma.
Kim SH; Lee KG; Kim TS
Acta Cytol; 2007; 51(3):375-9. PubMed ID: 17536538
[TBL] [Abstract][Full Text] [Related]
39. Imaging characteristics and growth of subependymal giant cell astrocytomas.
Clarke MJ; Foy AB; Wetjen N; Raffel C
Neurosurg Focus; 2006 Jan; 20(1):E5. PubMed ID: 16459995
[TBL] [Abstract][Full Text] [Related]
40. Surgical resection of subependymal giant cell astrocytomas (SEGAs) and changes in SEGA-related conditions: a US national claims database study.
Sun P; Krueger D; Liu J; Guo A; Rogerio J; Kohrman M
Curr Med Res Opin; 2012 Apr; 28(4):651-6. PubMed ID: 22375957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
